- DELIVERING ECONOMIC IMPACT THROUGH INNOVATIONWith more than $122 million in sponsored funding, our research generated an economic impact of $319 million in fiscal year 2018. Across campus, Georgia State scientists are working to solve global problems and produce tomorrow’s life-changing inventions and technologies.News
- SPOTLIGHT: UNIVERSAL FLU VACCINESeasonal flu vaccines are often unreliable because they can only target specific strains of the virus. Bao-Zhong Wang, associate professor in the Institute for Biomedical Sciences, is working to develop a “super vaccine” by targeting an interior part of the virus’ surface protein, called the hemagglutinin stalk. This interior part is the same in all influenza viruses, meaning the vaccine would be effective against virtually any strain.News
- SPOTLIGHT: FIGHTING THE FLUGeorgia State researchers have made new strides in their race to develop the world's first universal flu vaccine, which would eliminate the need for seasonal vaccinations and offer protection against all strains of the virus. A study released in January shows that their unique vaccine combination, which combines two major influenza proteins, can provide broad, long-lasting protection against six different flu strains in mice. Next, the researchers plan to load this double-layered nanoparticle vaccine onto microneedle patches for skin vaccination.News
powered by RSS Just Better 1.4 plugin
About the Center for Molecular and Translational Medicine
The Center for Molecular and Translational Medicine at Georgia State University meets healthcare needs by converting significant research findings into diagnostic tools and medicines to improve the health of individuals. The center is designed to help millions of people suffering from heart disease, diabetes and other illnesses. The current research focus of the center is to dissect molecular insights of cardiovascular remodeling in obesity and obesity related diseases, including diabetes, hypertension, heart diseases, and stroke, with special emphasis on the regulation of these processes.
Ming-Hui Zou, an internationally recognized researcher in molecular and translational medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine and associate vice president for research at Georgia State University, is the founding director of the Center for Molecular and Translational Medicine at Georgia State.
An independent investigator of the National Institutes of Health, the Juvenile Diabetes Research Foundation International, and the American Diabetes Association, and a National Scientist Development and National Established Investigator awardee of the American Heart Association, Zou has used these (and many other awards) to make scientific observations in fields with great potential for immediate clinical relevance.Read more about Zou
We effectively transform information gained from biomedical research into knowledge improving the state of human health and disease.